• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚乙烯基聚合物的物理化学性质及其对酮洛芬无定形固体分散体性能的影响:一个聚合物选择的案例研究

Physicochemical Properties of Poly-Vinyl Polymers and Their Influence on Ketoprofen Amorphous Solid Dispersion Performance: A Polymer Selection Case Study.

作者信息

Browne Emer, Worku Zelalem A, Healy Anne Marie

机构信息

SSPC The SFI Research Centre for Pharmaceuticals, School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin, Dublin 2, Ireland.

出版信息

Pharmaceutics. 2020 May 8;12(5):433. doi: 10.3390/pharmaceutics12050433.

DOI:10.3390/pharmaceutics12050433
PMID:32397201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7284699/
Abstract

When developing an amorphous solid dispersion (ASD), a prudent choice of polymer is critical to several aspects of ASD performance including: processability, solid state stability and dissolution rate. However, there is little guidance available to formulators to aid judicious polymer selection and a "trial and error" approach is often taken. This study aims to facilitate rational polymer selection and formulation design by generating ASDs using a range of poly-vinyl polymers and ketoprofen as a model active pharmaceutical ingredient (API) and evaluating several aspects of their performance. The molecular weight of the polymer and the ratio of vinyl pyrrolidone to vinyl acetate in the polymer were found to influence the relative humidity at which the relative humidity induced glass transition occurred, as well as the extent of ketoprofen supersaturation achieved during dynamic solubility testing. Interestingly, ASD tablets containing polymers with the vinyl pyrrolidone functional group exhibited higher tensile strengths than those without. This points towards the binder functionality of vinyl pyrrolidone. In conclusion, the physicochemical properties of poly-vinyl polymers greatly influence ketoprofen ASD performance and due regard should be paid to these properties in order to develop an ASD with the desired attributes.

摘要

在开发无定形固体分散体(ASD)时,谨慎选择聚合物对于ASD性能的多个方面至关重要,这些方面包括:可加工性、固态稳定性和溶解速率。然而,配方设计师在明智地选择聚合物方面几乎没有可参考的指导,通常采用“试错”方法。本研究旨在通过使用一系列聚乙烯基聚合物和酮洛芬作为模型活性药物成分(API)制备ASD,并评估其性能的多个方面,以促进合理的聚合物选择和配方设计。发现聚合物的分子量以及聚合物中乙烯基吡咯烷酮与醋酸乙烯酯的比例会影响相对湿度诱导玻璃化转变发生时的相对湿度,以及动态溶解度测试期间实现的酮洛芬过饱和度程度。有趣的是,含有具有乙烯基吡咯烷酮官能团聚合物的ASD片剂表现出比不含该官能团的片剂更高的拉伸强度。这表明了乙烯基吡咯烷酮的粘合剂功能。总之,聚乙烯基聚合物的物理化学性质极大地影响酮洛芬ASD的性能,为了开发具有所需特性的ASD,应充分考虑这些性质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86f/7284699/083e0d865757/pharmaceutics-12-00433-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86f/7284699/aa93ac6eb1ac/pharmaceutics-12-00433-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86f/7284699/437cefe0d46a/pharmaceutics-12-00433-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86f/7284699/54ffca3c582a/pharmaceutics-12-00433-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86f/7284699/a17a913ed354/pharmaceutics-12-00433-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86f/7284699/083e0d865757/pharmaceutics-12-00433-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86f/7284699/aa93ac6eb1ac/pharmaceutics-12-00433-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86f/7284699/437cefe0d46a/pharmaceutics-12-00433-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86f/7284699/54ffca3c582a/pharmaceutics-12-00433-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86f/7284699/a17a913ed354/pharmaceutics-12-00433-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a86f/7284699/083e0d865757/pharmaceutics-12-00433-g006.jpg

相似文献

1
Physicochemical Properties of Poly-Vinyl Polymers and Their Influence on Ketoprofen Amorphous Solid Dispersion Performance: A Polymer Selection Case Study.聚乙烯基聚合物的物理化学性质及其对酮洛芬无定形固体分散体性能的影响:一个聚合物选择的案例研究
Pharmaceutics. 2020 May 8;12(5):433. doi: 10.3390/pharmaceutics12050433.
2
Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.通过热熔挤出和条粒化制备双聚合物无定形固体分散体的配方性能和可加工窗口。
Int J Pharm. 2018 Dec 20;553(1-2):408-421. doi: 10.1016/j.ijpharm.2018.10.035. Epub 2018 Oct 14.
3
Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.溶剂对无定形固体分散体的相行为和玻璃化转变的影响。
Eur J Pharm Biopharm. 2021 Jan;158:132-142. doi: 10.1016/j.ejpb.2020.11.002. Epub 2020 Nov 16.
4
Physical stability of API/polymer-blend amorphous solid dispersions.原料药/聚合物共混无定形固体分散体的物理稳定性。
Eur J Pharm Biopharm. 2018 Mar;124:147-157. doi: 10.1016/j.ejpb.2017.12.002. Epub 2017 Dec 18.
5
Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.利托那韦-共聚维酮无定形固体分散体的溶解机制研究:一致释放对于增强性能的重要性。
Mol Pharm. 2019 Mar 4;16(3):1327-1339. doi: 10.1021/acs.molpharmaceut.8b01261. Epub 2019 Feb 5.
6
Amorphous solid dispersions of ketoprofen and poly-vinyl polymers prepared via electrospraying and spray drying: A comparison of particle characteristics and performance.通过静电喷雾和喷雾干燥制备的酮洛芬与多聚体聚合物无定形固体分散体:颗粒特性和性能比较。
Int J Pharm. 2019 Jul 20;566:173-184. doi: 10.1016/j.ijpharm.2019.05.062. Epub 2019 May 24.
7
Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.药物-聚合物-水相互作用及其对无定形固体分散体溶解性能的影响。
Mol Pharm. 2015 Feb 2;12(2):576-89. doi: 10.1021/mp500660m. Epub 2015 Jan 12.
8
Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.药物和聚合物的一致释放:无定形固体分散体溶解中的“最佳点”。
J Control Release. 2019 Mar 28;298:68-82. doi: 10.1016/j.jconrel.2019.01.039. Epub 2019 Feb 4.
9
Influence of humidity on the phase behavior of API/polymer formulations.湿度对活性药物成分/聚合物制剂相行为的影响。
Eur J Pharm Biopharm. 2015 Aug;94:352-62. doi: 10.1016/j.ejpb.2015.06.009. Epub 2015 Jun 24.
10
Tailored ASD destabilization - Balancing shelf life stability and dissolution performance with hydroxypropyl cellulose.定制的动脉粥样硬化斑块不稳定化——用羟丙基纤维素平衡保质期稳定性和溶解性能。
Int J Pharm X. 2023 Jun 7;5:100187. doi: 10.1016/j.ijpx.2023.100187. eCollection 2023 Dec.

引用本文的文献

1
Fine-Tuning the Physicochemical Properties of Poly(lactic Acid) Nanoparticles for the Controlled Release of the BET Inhibitor JQ1: Influence of PVA Concentration.微调聚乳酸纳米颗粒的物理化学性质以实现 BET 抑制剂 JQ1 的控释:聚乙烯醇浓度的影响
Polymers (Basel). 2025 Jan 6;17(1):123. doi: 10.3390/polym17010123.
2
Physicochemical Properties of Carbon Fiber Formulated from Melt-Spun Raw Asphaltene.由熔纺原生沥青质制成的碳纤维的物理化学性质
ACS Omega. 2024 Dec 11;9(51):50318-50325. doi: 10.1021/acsomega.4c06464. eCollection 2024 Dec 24.
3
Bulk Free Radical Terpolymerization of Butyl Acrylate, 2-Methylene-1,3-Dioxepane and Vinyl Acetate: Terpolymer Reactivity Ratio Estimation.

本文引用的文献

1
Investigation of Dissolution Mechanism and Release Kinetics of Poorly Water-Soluble Tadalafil from Amorphous Solid Dispersions Prepared by Various Methods.不同方法制备的难溶性他达拉非无定形固体分散体的溶出机制及释放动力学研究
Pharmaceutics. 2019 Aug 2;11(8):383. doi: 10.3390/pharmaceutics11080383.
2
Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.药物和聚合物的一致释放:无定形固体分散体溶解中的“最佳点”。
J Control Release. 2019 Mar 28;298:68-82. doi: 10.1016/j.jconrel.2019.01.039. Epub 2019 Feb 4.
3
Mechanism of Enhanced Nifedipine Dissolution by Polymer-Blended Solid Dispersion through Molecular-Level Characterization.
丙烯酸丁酯、2-亚甲基-1,3-二氧六环和醋酸乙烯酯的本体自由基三元共聚合:三元共聚物反应活性比的估算
Polymers (Basel). 2024 May 9;16(10):1330. doi: 10.3390/polym16101330.
4
Molecular structure of ketoprofen-polyvinylpyrrolidone solid dispersions prepared by different amorphization methods.通过不同非晶化方法制备的酮洛芬-聚乙烯吡咯烷酮固体分散体的分子结构
RSC Pharm. 2024 Mar 4;1(1):121-131. doi: 10.1039/d3pm00038a. eCollection 2024 Apr 18.
5
In Vitro and In Vivo testing of 3D-Printed Amorphous Lopinavir Printlets by Selective Laser Sinitering: Improved Bioavailability of a Poorly Soluble Drug.通过选择性激光烧结对3D打印的无定形洛匹那韦微丸进行体外和体内测试:提高难溶性药物的生物利用度。
AAPS PharmSciTech. 2024 Jan 24;25(1):20. doi: 10.1208/s12249-023-02729-y.
6
Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology.利用无定形固体分散技术解决研发阶段的药物制剂问题。
Recent Adv Drug Deliv Formul. 2024;18(2):79-99. doi: 10.2174/0126673878271641231201065151.
7
Poly(Vinyl Acetate) Paints: A Literature Review of Material Properties, Ageing Characteristics, and Conservation Challenges.聚醋酸乙烯酯涂料:材料性能、老化特性及保护挑战的文献综述
Polymers (Basel). 2023 Nov 7;15(22):4348. doi: 10.3390/polym15224348.
8
Functional Fiber Membranes with Antibacterial Properties for Face Masks.用于口罩的具有抗菌性能的功能性纤维膜
Adv Fiber Mater. 2023 May 17:1-15. doi: 10.1007/s42765-023-00291-7.
9
Combination of Dissolving Microneedles with Nanosuspension and Co-Grinding for Transdermal Delivery of Ketoprofen.溶蚀性微针与纳米混悬液联合及共研磨用于酮洛芬的透皮给药
Pharmaceuticals (Basel). 2023 Mar 1;16(3):378. doi: 10.3390/ph16030378.
10
Formulation Characterization and Pharmacokinetic Evaluation of Amorphous Solid Dispersions of Dasatinib.达沙替尼无定形固体分散体的制剂表征与药代动力学评价
Pharmaceutics. 2022 Nov 13;14(11):2450. doi: 10.3390/pharmaceutics14112450.
聚合物共混固体分散体增强硝苯地平溶出度的分子水平表征机制。
Mol Pharm. 2018 Sep 4;15(9):4099-4109. doi: 10.1021/acs.molpharmaceut.8b00523. Epub 2018 Aug 13.
4
Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs.聚合物无定形固体分散体:生物药剂学分类系统II类药物的非晶化、结晶、稳定化、固态表征及水相增溶综述
J Pharm Sci. 2016 Sep;105(9):2527-2544. doi: 10.1016/j.xphs.2015.10.008. Epub 2016 Jan 23.
5
Influence of PVP/VA copolymer composition on drug-polymer solubility.聚乙烯吡咯烷酮/醋酸乙烯酯共聚物组成对药物-聚合物溶解度的影响。
Eur J Pharm Sci. 2016 Mar 31;85:10-7. doi: 10.1016/j.ejps.2016.01.026. Epub 2016 Jan 28.
6
Influence of Copolymer Composition on In Vitro and In Vivo Performance of Celecoxib-PVP/VA Amorphous Solid Dispersions.共聚物组成对塞来昔布 - PVP/VA无定形固体分散体体外及体内性能的影响
AAPS J. 2016 Mar;18(2):416-23. doi: 10.1208/s12248-016-9865-6. Epub 2016 Jan 14.
7
Hydrogen Bonding Interactions in Amorphous Indomethacin and Its Amorphous Solid Dispersions with Poly(vinylpyrrolidone) and Poly(vinylpyrrolidone-co-vinyl acetate) Studied Using (13)C Solid-State NMR.采用(13)C 固体核磁共振研究无定形吲哚美辛及其与聚(乙烯基吡咯烷酮)和聚(乙烯基吡咯烷酮-共-醋酸乙烯酯)的无定形固体分散体中的氢键相互作用。
Mol Pharm. 2015 Dec 7;12(12):4518-28. doi: 10.1021/acs.molpharmaceut.5b00705. Epub 2015 Nov 12.
8
Comparative Study of Different Methods for the Prediction of Drug-Polymer Solubility.不同药物-聚合物溶解度预测方法的比较研究
Mol Pharm. 2015 Sep 8;12(9):3408-19. doi: 10.1021/acs.molpharmaceut.5b00423. Epub 2015 Aug 11.
9
Downstream processing of polymer-based amorphous solid dispersions to generate tablet formulations.聚合物无定形固体分散体的下游处理以生成片剂制剂。
Int J Pharm. 2015;486(1-2):268-86. doi: 10.1016/j.ijpharm.2015.03.053. Epub 2015 Mar 28.
10
Influence of Polymer Molecular Weight on Drug-Polymer Solubility: A Comparison between Experimentally Determined Solubility in PVP and Prediction Derived from Solubility in Monomer.聚合物分子量对药物-聚合物溶解度的影响:PVP中实验测定溶解度与由单体溶解度推导的预测值之间的比较。
J Pharm Sci. 2015 Sep;104(9):2905-12. doi: 10.1002/jps.24410. Epub 2015 Mar 3.